2025
SJR Q2
JCR Q3 · 2,5
120 matched articles
SCIE
Journal detail
Japanese Journal of Clinical Oncology
- Publisher
- Oxford University Press
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0368281114653621
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,652
- Quartile Q2
- H-Index 102
- Cites/doc 2,2
- Docs (3y) 555
- Cites (3y) 1.188
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,5
- 5Y JIF 2,3
- JCI 0,43
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,652 | 2,5 | 2,3 | 0,43 | Q3 | 102 |
| 2024 | Q2 | Q3 | 0,613 | 2,2 | 2,4 | 0,4 | Q3 | 98 |
| 2023 | Q2 | Q3 | 0,612 | 1,9 | 2,4 | 0,43 | Q3 | 98 |
| 2022 | Q2 | Q4 | 0,743 | 2,4 | 2,6 | 0,46 | Q3 | 98 |
| 2021 | Q2 | Q3 | 0,679 | 2,9 | 2,9 | 0,49 | Q3 | 98 |
| 2020 | Q2 | Q3 | 0,768 | 3 | 2,8 | 0,49 | Q3 | 98 |
| 2019 | Q2 | Q4 | 0,758 | 1,9 | 2,2 | 0,5 | Q3 | 98 |
| 2018 | — | Q3 | — | 2,2 | 2,1 | 0,53 | Q3 | — |
| 2017 | Q1 | Q3 | 0,942 | 2,4 | 2,1 | 0,51 | Q3 | 98 |
| 2016 | Q1 | Q4 | 0,896 | 1,9 | 1,9 | — | — | 98 |
| 2015 | Q1 | Q4 | 0,87 | 1,9 | 2 | — | — | 98 |
| 2014 | Q1 | Q3 | 0,882 | 2 | 2 | — | — | 98 |
| 2013 | Q1 | Q3 | 0,964 | 1,7 | 2,1 | — | — | 98 |
| 2012 | Q1 | Q3 | 0,924 | 1,9 | 2,1 | — | — | 98 |
| 2011 | Q1 | Q3 | 0,855 | 1,8 | 1,9 | — | — | 98 |
| 2010 | Q2 | Q3 | 0,75 | 1,9 | 1,8 | — | — | 98 |
| 2009 | — | Q3 | — | 1,5 | 1,7 | — | — | — |
| 2008 | — | Q4 | — | 1,4 | 1,7 | — | — | — |
| 2007 | — | Q4 | — | 1,3 | 1,3 | — | — | — |
| 2006 | — | Q4 | — | 1,4 | — | — | — | — |
| 2005 | — | Q4 | — | 1,3 | — | — | — | — |
| 2004 | — | Q4 | — | 1 | — | — | — | — |
| 2003 | — | Q4 | — | 0,8 | — | — | — | — |
| 2002 | — | Q4 | — | 0,7 | — | — | — | — |
| 2001 | — | Q4 | — | 0,6 | — | — | — | — |
| 2000 | — | Q4 | — | 0,8 | — | — | — | — |
| 1999 | — | Q4 | — | 0,7 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
| 1997 | — | Q4 | — | 0,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 204/333 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q3 | 217/328 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q3 | 234/322 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q3 | 189/241 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q3 | 183/245 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q3 | 181/242 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q3 | 209/244 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q3 | 171/230 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q3 | 159/223 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 164/217 |
| 2015 | ONCOLOGY | SCIE | Q4 | — | 160/213 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 151/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 152/203 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 136/197 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 135/196 |
| 2010 | ONCOLOGY | SCIE | Q3 | — | 128/185 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 122/166 |
| 2008 | ONCOLOGY | SCIE | Q4 | — | 120/143 |
| 2007 | ONCOLOGY | SCIE | Q4 | — | 115/132 |
| 2006 | ONCOLOGY | SCIE | Q4 | — | 108/127 |
| 2005 | ONCOLOGY | SCIE | Q4 | — | 98/123 |
| 2004 | ONCOLOGY | SCIE | Q4 | — | 107/123 |
| 2003 | ONCOLOGY | SCIE | Q4 | — | 104/120 |
| 2002 | ONCOLOGY | SCIE | Q4 | — | 102/114 |
| 2001 | ONCOLOGY | SCIE | Q4 | — | 93/107 |
| 2000 | ONCOLOGY | SCIE | Q4 | — | 85/103 |
| 1999 | ONCOLOGY | SCIE | Q4 | — | 86/105 |
| 1998 | ONCOLOGY | SCIE | Q3 | — | 78/104 |
| 1997 | ONCOLOGY | SCIE | Q4 | — | 88/102 |